Search

everythinglearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Skin cells control immune cell placement, helping the skin respond better to challenges.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

ILC1-like cells may contribute to hair loss in alopecia areata.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Developing human skin has immune cells with memory-like features.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Inflammation in hair follicles is a key risk factor for developing common baldness.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.